Other OTC - Delayed Quote USD

Kraig Biocraft Laboratories, Inc. (KBLB)

0.0870 -0.0010 (-1.14%)
At close: April 19 at 3:37 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Kim Kraig Thompson Founder, Chairman, CEO, President, CFO & Corporate Secretary 594.07k -- 1961
Mr. Jonathan R. Rice Chief Operating Officer 204.32k -- 1980
Mr. Kenneth Le Director of Government Relations & President of Prodigy Textiles 60k -- 1966
Dr. Trevor L. Kane Chief Scientist & Member of Scientific Advisory Board -- -- --

Kraig Biocraft Laboratories, Inc.

2723 South State Street
Suite 150
Ann Arbor, MI 48104
United States
734 619 8066 https://www.kraiglabs.com
Full Time Employees: 
37

Description

Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company's products are used in military and police, and defense applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.

Corporate Governance

Kraig Biocraft Laboratories, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Apr 01, 2024
    8-K: Corporate Changes & Voting Matters
    See Full Filing
  • Nov 22, 2023
    S-1/A: Offering Registrations
    See Full Filing
  • Nov 13, 2023
    10-Q: Periodic Financial Reports
    See Full Filing
  • Sep 01, 2023
    POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
    See Full Filing
  • Aug 14, 2023
    10-Q: Periodic Financial Reports
    See Full Filing

Upcoming Events

May 10, 2024 - May 14, 2024
Kraig Biocraft Laboratories, Inc. Earnings Call

Related Tickers

GVDNY Givaudan SA
87.01
+1.94%
 
NVZMY Novozymes A/S
55.03
+1.05%
 
NNOMF Nano One Materials Corp.
1.2007
-1.58%
 
MATV Mativ Holdings, Inc.
17.88
+1.59%
 
GMGMF Graphene Manufacturing Group Ltd
0.3680
-8.00%
 
CNEY CN Energy Group. Inc.
0.7100
-5.33%
 
CC The Chemours Company
25.91
-2.15%
 
SNES SenesTech, Inc.
0.7179
-2.13%
 
LWLG Lightwave Logic, Inc.
4.0200
-1.95%
 
DD DuPont de Nemours, Inc.
73.89
+0.49%